Abstract
Eptifibatide is a commonly and widely used drug for management of acute coronary syndrome and during percutaneous coronary intervention. It is usually well tolerated with no major adverse effects. We report a rare case of life-threatening thrombocytopenia secondary to eptifibatide along with a literature review of available evidence.
MeSH terms
-
Aged
-
Eptifibatide
-
Humans
-
Male
-
Peptides / adverse effects*
-
Platelet Aggregation Inhibitors / adverse effects*
-
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
-
Thrombocytopenia / chemically induced*
Substances
-
Peptides
-
Platelet Aggregation Inhibitors
-
Platelet Glycoprotein GPIIb-IIIa Complex
-
Eptifibatide